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The 16-kDa cytosolic antigen of M. tuberculosis was purified to homogeneity by molecular sieving chroma-
tography, and the diagnostic potential of the antigen was evaluated in various categories of patients by
enzyme-linked immunosorbent assay (ELISA). The immunoglobulin G (IgG), IgA, and IgM antibody levels to
16-kDa antigen were estimated in the two polar groups, namely, smear- and culture-positive pulmonary
tuberculosis (SC) patients and healthy subjects (HS). Sensitivities of 62, 52 and 11% with specificities of
100, 97, and 95% were obtained for the three isotypes, respectively. The total number of positives by a
combination of the three isotypes was analyzed in the polar groups, and the sensitivity improved to 83% with
a specificity of 93%. Even when a combination of IgG and IgA alone was considered, the sensitivity was 82%
with a specificity of 97%. Polyethylene glycol precipitation of the circulating immune complex (CIC) in sera was
carried out. The CIC-bound antibodies to 16-kDa antigen were assessed by ELISA in the SC, SC, and
SC categories of patients. Measuring the IgG-IgA-IgM combination positivities of the CIC-bound antibodies
gave sensitivities of 97.5, 100, and 45.3%, respectively. The specificity of the assay with these combinations was
maintained at 95.4%.
Tuberculosis is a major health problem throughout the
world, resulting in about 3 million deaths annually (17). This
contagious disease, though preventable, has had an increased
incidence in recent years, mainly due to its association with
human immunodeficiency virus disease (30) and also due to
the occurrence of multidrug resistance (36). In spite of the
availability of an adequate treatment regimen, attempts to
restrict and eradicate the disease have failed.
The alarming increase in morbidity and mortality due to
tuberculosis indicates the need to strengthen control measures.
Control of the disease depends largely on early detection and
treatment of active cases. There is promise in serodiagnostic
tests like enzyme-linked immunosorbent assay (ELISA) be-
cause of their ease of performance and cost-effectiveness. Se-
rodiagnosis was attempted in earlier days, using crude and
semipurified antigens, and was found to give different ranges of
sensitivity and specificity (10, 14). The results underline the
importance of identifying species-specific antigens and using
them for diagnosis.
Daniel and Anderson (12) were the first to report on the
species-specific antigen 5 of Mycobacterium tuberculosis, which
was later proved to be the same as the 38-kDa antigen. As
antigen 5, it has shown high specificity in all studies conducted
in different parts of the world (88 to 98%), while the sensitivity
varied from 49 to 89% (2, 3, 13, 15, 23). Other than this and a
limited number of other antigens, species specificity (at least
M. tuberculosis complex specificity) is quite rare among the M.
tuberculosis antigens.
In a preliminary study of immunoblots with patients’ sera,
we observed the specific recognition of a 16- or 17-kDa band by
pooled tuberculous sera, which encouraged us to attempt the
isolation of this protein. In the present study, the 16-kDa
antigen has been purified from the cytosol fraction of M. tu-
berculosis H37Rv and evaluated for its diagnostic potential in
the sera of various categories of tuberculosis patients by
ELISA. Anti-16-kDa antibodies bound to the circulating im-
mune complex (CIC) in the same groups of patients were also
measured.
MATERIALS AND METHODS
Study population. This study has complied with the relevant governmental
guidelines and was approved by our institutional Scientific Advisory Committee
and Ethical Committee. Informed consent was obtained from the study popula-
tion before blood was drawn.
Sera were obtained from the various categories of patients and healthy indi-
viduals, as described below. A total of 555 sera were used in the study, 345 of
which were obtained from pulmonary tuberculosis patients, which could be
subdivided into the following groups. (i) Smear- and culture-positive cases,
pretreatment (SC) (n  175). Smear and culture examination were done
according to standard procedures (1). Two spot and one overnight sputum
specimens were collected from each patient, and direct smears stained for acid-
fast bacilli were observed under a fluorescent microscope. The sputa were also
decontaminated, concentrated, and inoculated on Lowenstein-Jenson medium
and incubated for up to 8 weeks at 37°C to check positivity and negativity. (ii)
Smear-negative, culture-positive cases, pretreatment (SC) (n  41). (iii)
Smear- and culture-negative, clinically and radiologically diagnosed cases (SC
[X-ray]) (n  50). The X rays were read by two independent readers (and by one
more reader in case of disagreement between the two) and classified as possible
or probable tuberculosis. This group formed part of a sample survey for preva-
lence of the disease in the community (16). (iv) Smear- and culture-negative
cases, treated and remaining quiescent for at least 5 years (SC [treated]) (n 
79).
A total of 210 sera were obtained from controls, as follows. (i) Patients with
nontuberculous lung diseases (non-TB) (n  60). This category includes condi-
tions that present with X-ray shadows, such as asthma, allergy, etc.; lung carci-
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noma; other infectious conditions likely to have cross-reactive antigens, such as
nocardiasis; and patients with lung pathology in whom mycobacteria other than
M. tuberculosis have been isolated. (ii) Healthy subjects from the laboratory and
voluntary donors from a blood bank (HS) (n  150).
The sera were aliquoted and stored at 70°C till the time of use.
Purification of 16-kDa antigen. M. tuberculosis H37Rv sonicate and cytosol
antigens were prepared as described earlier (32).
The cytosol fraction of the sonicate antigen of M. tuberculosis H37Rv was
passed through gel filtration chromatography using Ultrogel ACA34 matrix
(Pharmacia, Uppsala, Sweden). Initially, 150 mg of the cytosol fraction was
loaded on the gel filtration column (75 by 5 cm) along with bromophenol blue
and blue dextran to serve as indicators for the mobility of samples. The elution
was carried out with 20 mM Tris-HCl buffer along with 1 mM EDTA, 1 mM
dithiothreitol, and 0.5 M NaCl at pH 8.2. The cytosol antigens separated by
Ultrogel ACA34 were collected as 1-ml fractions at a rate of 0.75 ml per min. A
total of 350 fractions were collected.
The quantification of the proteins was done with a bicinchoninic acid protein
assay kit (Pierce, Rockford, Ill.).
Analytical SDS-PAGE. The cytosol and fractions were analyzed by sodium
dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) by the method
of Laemmli (21), using a 12.5% resolving gel. After electrophoresis, the gels were
stained with 0.2% Coomassie brilliant blue stain.
ELISA. ELISA was carried out to estimate the immunoglobulin G (IgG), IgA,
and IgM antibody levels against the 16-kDa antigen of M. tuberculosis H37Rv as
described previously (34). The coating concentration of antigen was 0.2 g/ml.
The sera were tested at 1/3,200.
CIC precipitation. The method of CIC precipitation with polyethylene glycol
(PEG) has been described elsewhere (29). Reconstituted PEG precipitates (1/
100 dilution) were tested for the presence of anti-16-kDa antibodies of the
classes IgG, IgA, and IgM by ELISA.
In experiment 1, four categories of sera, namely, SC (n  20), SC(n 
26), SC (n  37), and HS (n  39) were randomly selected and subjected to
CIC precipitation with 3.5% PEG. The CIC-bound 16-kDa antibodies were
measured, and the number of positives in each category was calculated as before
(greater than the mean plus 2 standard deviations [SD] of HS).
The experiment was repeated (experiment 2) with another set of sera (SC
[n 20]. SC [n 26], SC [n 27], and HS [n 48]) to test reproducibility.
The results of experiments 1 and 2 were merged and analyzed.
RESULTS
Purification of 16-kDa antigen. The cytosol antigens were
separated on a gel filtration column. Every fifth fraction col-
lected was analyzed by SDS–12.5% PAGE after being stained
with Coomassie brilliant blue stain. The SDS-PAGE analysis
of the purified protein is shown in Fig. 1.
Characterization of 16-kDa antigen. The protein purified by
gel filtration chromatography was subjected to reverse-phase
high-performance liquid chromatography (HPLC) in order to
ascertain the homogeneity of the protein. Ten micrograms of
protein was loaded on a C18 column. The run was carried out
with an isocratic flow of 30% acetonitrile with a 0.2-ml/min
flow rate. The protein was eluted at retention times (RT) of 9
and 13 min. The individual fractions obtained at the two time
points were analyzed on SDS-PAGE. The peak obtained at an
RT of 9 min showed a protein in the 16-kDa region, while the
peak at 13 min was found to contain a band in the 16-kDa
region as well as a band in the 32-kDa region (data not shown).
The circular dichroism (CD) spectrum for the purified pro-
tein was analyzed and showed a maximum peak at 214 nm with
a molar ellipticity of 65,779.9° cm2 · dmol1, characteristic of
-sheet structure (data not shown).
The identity of the purified 16-kDa antigen was established
by an immunoblot with monoclonal antibodies (MAbs) IT-1
and IT-4 from the World Health Organization bank and a
polyclonal antibody against H37Rv as a positive control. A
positive reaction with the established MAbs suggests identity
of this protein with the already reported 16-kDa antigen (data
not shown).
Serum antibody levels. (i) Polar groups. The serum antibod-
ies in the two polar groups, namely, the SC and the HS
groups, were measured. The mean optical densities (ODs) for
IgG, IgA, and IgM obtained for the SC group were 0.338,
0.367, and 0.453, respectively. In the case of the HS group, the
mean ODs were observed to be 0.187, 0.162, and 0.373, re-
spectively, which were significantly less (p 0.0001) than those
of the tuberculous patients.
Using a cutoff of greater than the mean plus 2 SD of HS, the
sensitivities of the assay in SC cases were 62.28, 52, and
10.85% for the three isotypes IgG, IgA, and IgM, respectively.
The number and percentage of positives in the two polar
groups are given in Table 1. The maximum number of positives
was seen with IgG antibody. However, when individual results
were scrutinized, it was observed that some sera negative for
IgG were positive for IgA and/or IgM. By combining the re-
sults for IgG and IgA, the sensitivity of the assay was increased
to 82.28%, while the specificity remained at 96.6%. When the
results for IgM were also combined, the sensitivity was 82.85%
and the specificity decreased to 93.3%.
(ii) Other groups. In the SC cases, positivities of 39%
with both IgG and IgA and 9.75% with IgM were obtained. In
the SC (X-ray-positive) cases, the antigen identified 58% as
positive for IgG, 38% positive for IgA, and none positive for
IgM.
For the SC (treated) cases, positivities of 20.25% (IgG),
25.31% (IgA), and 1.26% (IgM) were obtained. Among the
non-TB lung disease cases, the percentages positive for 16-kDa
FIG. 1. Purified 16-kDa protein on SDS-PAGE. Lane 1, molecular
mass marker; lane 2, purified 16-kDa protein.
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antigen were 40, 10, and 1.66% for the three isotypes. The
percentages positive in all these categories are shown in Table
2.
With a combination of IgG, IgA, and IgM isotypes, the
sensitivity increased to 74% in SC (X-ray) cases, increased
to 63.4% in SC cases, and remained similar (43%) in
non-TB lung disease cases.
CIC-bound antibody to 16-kDa antigen. The results of ex-
periments 1 and 2 were merged and are summarized in Table
3.
Among the SC cases, 35 of 40 were positive for CIC IgG.
In the SC group, 42 of 52 were positive, and in the SC
group, 21 of 64 were positive. Positivity for IgA antibodies, as
well as IgM antibodies, was also seen, as shown in Table 3. One
out of 87 HS CICs was positive for IgG (99% specificity). HS
CICs were also positive for IgA (two) and IgM (one). As seen
in Table 3, 97.5, 100, and 45% positivities were achieved for the
SC, SC, and SC groups for detection of all three of
the CIC-bound immunoglobulins. After combination of the
results, the specificity of the test was 95.4% (83 of 87).
Out of the 60 sera from patients with non-TB lung diseases,
13 which were false positive for anti-16-kDa serum IgG and 7
which were negative were tested for CIC IgG. All serum pos-
itives but one proved to be negative for CIC-bound antibodies
(results not shown).
DISCUSSION
Research for identification of a suitable antigen for serodi-
agnosis of tuberculosis has come a long way, and yet there is lot
more to be explored. In this study, a cytosol protein of 16-kDa
molecular mass was isolated from the virulent strain M. tuber-
culosis H37Rv and evaluated for its diagnostic value.
The 16-kDa protein belongs to the alpha crystallin super-
family of small heat shock proteins and has been variously
referred to as sHsp16, Hsp.16.3, Acr, and MPT63. It is similar
to the major membrane protein (22) and Nox16 (18) referred
to previously.
The antigen described in this study, isolated from the cytosol
fraction, has been assigned a mass of 16 kDa based on its
movement in SDS-PAGE. Further evidence for confirmation
of the identity of this protein with Hsp. 16.3, reported earlier,
comes from the study of the circular dichroism of this native
protein. Our purified protein has been assigned a predomi-
nantly -sheet structure with a peak in the 210- to 215-nm
region, which is in agreement with the report of Berengian et
al. (4). Further, a positive reaction of this protein with MAbs
IT-1 and IT-4 from the World Health Organization bank sug-
gests the similarity of this 16-kDa protein to the reported
16-kDa Hsp antigen.
The antigen seems to exist in two different molecular forms,
as two peaks at different RT were obtained from the purified
antigen preparation when it was analyzed by HPLC. However,
when the two peaks were separately analyzed by SDS-PAGE,
both peaks contained only the 16-kDa protein, which shows
that the protein exists in different oligomeric forms. Hsp.16.3
has been found to occur as oligomers consisting of a trimer of
trimers (a nine-subunit complex) (11, 37).
The species specificity of this antigen has been extensively
studied by various investigators. The mpt63 gene is found only
in species of the M. tuberculosis complex, as shown by DNA
hybridization studies (24). Antibodies against MPT63 do not
cross-react with common environmental mycobacteria (24).
Species-specific B-cell epitopes on this antigen have been dem-
onstrated (19), and it has also been shown that its TB68 MAb-
reacting epitope, as well as the T-cell clones, are specific for
the M. tuberculosis complex (27). In a preliminary study of
immunoblots with patients’ sera, we have observed the specific
recognition of a 16- or 17-kDa band by pooled tuberculous sera
(n  65) and not by pooled normal sera (n  65), which also
suggests the specificity of 16 kDa.
Effective serodiagnosis using 16-kDa antigen has been re-
ported by previous investigators, though only a limited number
TABLE 1. ELISA positivity in polar groupsa
Isotype









IgG 109 62 0 100
IgA 91 52 4 97
IgM 19 11 7 95
IgG  IgA 144 82 4 97
IgG  IgA  IgM 145 83 10 93
a Positivity is defined as greater than the mean plus 2 SD of HS OD.















SC (X ray) (n  50) 29 58 19 38 0 0
SC (n  41) 16 39 16 39 4 10
SC (treated) (n  79) 16 20 20 25 1 1
Non-TB lung diseases (n  60) 24 40 6 10 1 2











IgG 35 (87.5) 42 (80.7) 21 (32.8) 1 (1.0)
IgA 39 (97.5) 52 (100) 13 (20.3) 2 (2.2)
IgM 28 (70) 22 (42.3) 10 (15.6) 1 (1.0)
IgG  IgA 39 (97.5) 52 (100) 25 (39) 3 (3.4)
IgG  IgA  IgM 39 (97.5) 52 (100) 29 (45.3) 4 (4.5)
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of studies have been done with this antigen (22, 35). Other
groups of workers have evaluated a 14-kDa antigen (which was
later renamed Hsp16) and its epitopes (6, 20).
In all of the studies reported so far, only IgG has been
measured, and the sensitivities ranged from 70 to 75%. In our
study, a sensitivity of 62% was obtained in SC cases by
measuring IgG response alone, whereas when the IgA and IgM
isotype response were combined, the sensitivity increased to
83%. Our sensitivity results show an improvement over those
reported earlier, and the specificity (93%) is also comparable
to those reported with other preparations of 16-kDa antigen.
In smear-negative cases, the sensitivity reported with this
antigen was less. In the study conducted by Bothamley et al.
(6), 46 and 11% sensitivities were obtained with 16-kDa whole
antigen and the TB68 epitope, respectively. In another study,
the 16-kDa antigen identified 54% of cases (20). In our study,
using this antigen in the diagnosis of SC patients, there was
39% positivity for the IgG and IgA isotypes and 10% positivity
for the IgM isotype. By combining IgG, IgA, and IgM isotypes,
the sensitivity was increased to 63.4%. A similarly high sensi-
tivity of 74% was obtained for SC (X-ray) cases. Here again,
an improvement in test outcome by combining three isotypes is
demonstrated compared to IgG alone.
However, following a similar approach, the false positivity
was very high (43%) in non-TB lung diseases. Cutoff limits of
the mean plus 3 SD were used, and the results were recalcu-
lated. This did not eliminate the nonspecificity in this group, as
19 of 60 cases (31.7%) were still positive
Since the antigen is species specific, the false positivity may
be attributed to nonspecific hyperglobulinemia, common in
bronchial diseases (7), or other causes. Irrespective of the
reason, this is a complicating factor in diagnosis and is likely to
compromise the specificity of the assay when applied in clinical
situations. Therefore, the value of the 16-kDa antigen for di-
agnosis based on serum antibodies is limited.
A large number of studies have reported the presence of
CIC in tuberculous patients (8, 9, 25). Many of these studies
measured the mycobacterial antigens (5, 25, 31) only after
breaking the complex and concentrating them. Demonstration
of antimycobacterial antibodies in CIC has posed fewer prob-
lems (5, 25, 31).
In one of our previous studies (29), we demonstrated that
PEG-precipitable CICs are present in smear-positive, as well
as smear-negative, patients’ sera. In fact, the quantity of CIC
(as judged by the OD at 280 nm) was significantly higher in
smear-negative cases. Anti-mycobacterial-antibody measure-
ment in CICs was more discriminatory between the groups
than serum antibody measurement.
In the present study, we have measured CIC-bound antibod-
ies of the classes IgG, IgA, and IgM against the 16-kDa anti-
gen. While the majority of the CIC was IgG positive, IgA and
IgM could also be measured. It was observed that many tuber-
culous sera, which were negative for free antibody, were pos-
itive for complexed antibody. Detection of anti-16-kDa anti-
bodies in CIC greatly improved the outcome of the test,
showing 97.5% sensitivity in the SC group. Among SC
cases, too, 52 of 52 were positive for CIC antibodies, and
among SC radiologically diagnosed cases, 45% were posi-
tive for CIC antibodies. Thus, these results reconfirm our pre-
vious observation of 100% sensitivity in culture-proven cases
(29).
Out of the 60 sera from non-TB lung disease patients, 13
which were false positive for anti-16-kDa serum IgG and 7
which were negative were tested for CIC IgG. All serum pos-
itives but one proved to be negative for CIC-bound antibodies.
Thus, the interfering serum component contributing to non-
specific high OD was removed. This is not a chance phenom-
enon, since we have also reported similar results for a 38-kDa
antigen in the same study population (34).
The absence of antibody response to any particular antigen
is generally interpreted as being due to immunosuppression or
the absence of recognition due to host genetic factors. As early
as 1980 (9), an inverse relationship between serum C1q binding
and serum anti-Mycobacterium bovis BCG antibody was ob-
served, suggesting that some antibodies may be bound to the
complexes. Here, we have demonstrated that the absence of
anti-16-kDa antibody in the free form could be due to its
sequestration in the bound form.
Earlier studies by other authors have reported the detection
of CIC antibodies against glycolipid antigens (phosphatidyl
inositomannoside and diacyl trehalose), as well as protein an-
tigens (antigen 5) (26, 28, 33). The diagnostic value of anti-16-
kDa CIC antibodies has not been reported so far. Our study
has demonstrated a high sensitivity of detection of S cases, as
well as S cases, where diagnosis is most needed. The CIC
antibody-based diagnosis, owing to its high sensitivity and spec-
ificity, can be useful for (i) individual patient-based diagnosis;
(ii) detection of cases under Tuberculosis Control Program
conditions, compared to sputum smears; and (iii) detection of
cases while screening populations, compared to X rays.
The method involves overnight incubation, centrifugation,
etc. Therefore, it cannot be viewed as a rapid test to be per-
formed under field conditions. However, a large number of
samples can be brought to a central laboratory and processed
together. As for the time involved in incubation, the test is
comparable to the sputum smear, since at least three sputum
collections from the same patient (two spot and one overnight)
are to be tested under Tuberculosis Control Program condi-
tions. Even then, false negativity can be seen in the smear test,
which is overcome by CIC ELISA. (In the present study, spu-
tum smears diagnosed 175 out of 216 [81%] culture-positive
cases, while CIC ELISA identified 91 of 92 (98.9%) culture-
positive cases.) Although three isotypes have to be measured,
they can be combined in a single test, since anti-human IgG-
IgA-IgM conjugates are commercially available. This test will
be especially useful in cases where sputum positivity is rare,
such as childhood tuberculosis, extrapulmonary tuberculosis,
and minimal disease.
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